comparemela.com

Latest Breaking News On - Painreform ltd - Page 15 : comparemela.com

PainReform Gains 5%

PainReform Ltd. (PRFX) shares are progressing more than 5 percent on Monday morning trade. There have been no corporate announcements today. The stock have been on an uptrend since June 30.

Painreform-ltd

PainReform : Form 20-F ☒ Form 40-F ☐

Form 20-F ☒ Form 40-F ☐ This Report on Form 6-K is incorporated by reference into the Company s Registration Statement on Form S-8 (Registration No. 333-257968 and 333-265902) a.

Painreform-ltd
Nasdaq-capital-market
Markets

PainReform (PRFX) Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110

PainReform (PRFX) Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Ilan-hadar
Painreform-ltd
Ilan-hadarchief-executive-officerpainreform-ltd-tel
Crescendo-communications-llctel
Exchange-commission
Nasdaq
Wall-street
Drug-master-file
Chief-executive-officer
Regarding-forward-looking-statementsthis
Annual-report

PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Ilan-hadar
Ilan-hadarchief-executive-officerpainreform-ltd-tel
Exchange-commission
Crescendo-communications-llctel
Nasdaq
Painreform-ltd
Drug-master-file
Chief-executive-officer
Regarding-forward-looking-statementsthis
Annual-report
Hadarchief-executive-officerpainreform-ltd-tel

PainReform's Phase 3 Trial Of PRF-110 Delayed Due To Supplier Issue

(RTTNews) - Shares of PainReform Ltd. (PRFX), a clinical-stage specialty pharmaceutical company, slipped nearly 14% in after-hours trading on Wedn.

Ilan-hadar
Painreform-ltd
Drug-master-file
Chief-executive-officer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.